Skip to main content
PeptideClock Logo Icon
PeptideClock
DashboardToolsGuidesDatabase
Peptide Category

GLP-1 Receptor Agonists

Glucagon-like peptide-1 (GLP-1) agonists are a class of peptides primarily used for glycemic control and weight management. They work by mimicking the incretin hormones that stimulate insulin secretion and suppress glucagon.

Liraglutide

Glycemic control in labeled use
Weight-loss efficacy in labeled obesity formulations
Appetite suppression in labeled use
View Research

Retatrutide

Triple-agonist obesity-trial research interest
Glycemic-control research interest
Liver-fat reduction research interest
View Research

Semaglutide

Glycemic control in regulated products
Weight-loss efficacy in regulated products
Cardiovascular outcome evidence in regulated products
View Research

Tirzepatide

Dual agonist (GLP-1 & GIP)
Weight-loss efficacy in obesity trials
Glycemic-control research interest
View Research

Frequently Asked Questions

What are GLP-1 peptides used for?

GLP-1 peptides are primarily studied in connection with insulin sensitivity, appetite and weight regulation, and cardiometabolic endpoints. These are research and regulated-product contexts, not outcomes established for unapproved research-vial use.

Do GLP-1 peptides need refrigeration?

Yes, most GLP-1 receptor agonists are proteins that require refrigeration (2-8°C) to maintain stability. They are generally robust but can degrade at room temperature over time.

What is the most stable GLP-1 peptide?

Semaglutide is considered one of the most stable GLP-1 analogs due to structural modifications that protect it from enzymatic degradation.